WHO ICTRP trial
A clinical trial to observe the effect of Pemetrexed in Combination with…
CTRI/2009/091/001066 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2009/091/001066 |
|---|---|
| Public title | A clinical trial to observe the effect of Pemetrexed in Combination with Cisplatin in Patients with Advanced stage IIIB/IV Non-Small Cell Lung Cancer patients in india |
| Scientific title | A Open-Label Single-Arm observational Study of Pemetrexed in Combination with Cisplatin in Patients with Advanced stage IIB/IV Non-Small Cell Lung Cancer (Adenocarcinoma & Large Cell carcinoma) to assess the PFS.(Progression Free Survival) in Indian context |
| Primary sponsor | Bhagwan Mahaveer Cancer Hospital Research Centre |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Countries | India |
| Conditions | Health Condition 1: null- Advanced Stage IIIB/IV Non Small Cell carcinoma of the Lung (Adenocarcinoma & Large cell carcinoma) |
| Interventions | Intervention1: Pemetrexed,Cisplatin: Pemetrexed 500 Mg/M2 Day 1 & every 3 weeks upto 6 cycles. Cisplatin 75 Mg/M2 Day 1 & every 3 weeks upto 6 cycles Control Intervention1: NONE: NONE |
| Registration date | Dec 23, 2009 |
| Target size | 35 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: